Hemcheck Sweden AB has received a new follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests (v-Test). The order is worth over EUR 10,000.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.108 SEK | 0.00% |
|
-12.20% | -54.62% |
05-13 | Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-14 | Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-54.62% | 3.02M | |
-12.05% | 7.33B | |
+0.92% | 5.35B | |
+32.11% | 5.68B | |
-18.56% | 3.71B | |
+5.52% | 2.49B | |
-64.99% | 2.35B | |
-10.99% | 2.22B | |
+28.84% | 2.23B | |
-15.91% | 1.61B |
- Stock Market
- Equities
- BIOVIT Stock
- News Bio Vitos Pharma AB
- Hemcheck Sweden Receives New Follow Up Order from the Foundation for Innovative New Diagnostics